UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$324M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$241M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$150M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$142M |
| 5 |
UBS Group
UBS
|
+$140M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$630M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$608M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$368M |
| 4 |
Tesla
TSLA
|
+$339M |
| 5 |
Amazon
AMZN
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.88% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.52% |
| 4 | Consumer Discretionary | 4.99% |
| 5 | Industrials | 4.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8701
Global X AgTech & Food Innovation ETF
KROP
$9.31M
| $8K | ﹤0.01% |
177
-10
| -5% | -$498 |
|
8702
Live Ventures
LIVE
$29M
| $8K | ﹤0.01% |
309
+33
| +12% | +$944 |
|
8703
Lucid Diagnostics
LUCD
$183M
| $8K | ﹤0.01% |
4,961
+374
| +8% | +$931 |
|
8704
Mediaco Holding
MDIA
$80.7M
| $8K | ﹤0.01% |
4,506
+1,250
| +38% | +$3.39K |
|
8705
Monopar Therapeutics
MNPR
$794M
| $8K | ﹤0.01% |
1,080
-2,832
| -72% | -$26.8K |
|
8706
Mobix Labs
MOBX
$27.5M
| $8K | ﹤0.01% |
77
+29
| +60% | +$2.92K |
|
8707
Maris-Tech
MTEK
$12.4M
| $8K | ﹤0.01% |
6,920
+6,888
| +21,525% | +$9.13K |
|
8708
Microvision
MVIS
$85.2M
| $8K | ﹤0.01% |
153
-6
| -4% | -$424 |
|
8709
ProShares UltraShort MidCap400
MZZ
$2.37M
| $8K | ﹤0.01% |
+380
| New | +$7.02K |
|
8710
Nature's Sunshine
NATR
$360M
| $8K | ﹤0.01% |
967
+399
| +70% | +$3.96K |
|
8711
Neuropace
NPCE
$482M
| $8K | ﹤0.01% |
+2,173
| New | +$10.5K |
|
8712
Navitas Semiconductor
NVTS
$3.31B
| $8K | ﹤0.01% |
1,700
-2,358
| -58% | -$12.2K |
|
8713
Puma Biotechnology
PBYI
$397M
| $8K | ﹤0.01% |
3,425
-1,114
| -25% | -$3.25K |
|
8714
State Street SPDR MSCI Emerging Markets StrategicFactors ETF
QEMM
$55.9M
| $8K | ﹤0.01% |
159
-495
| -76% | -$27.4K |
|
8715
Invesco ESG NASDAQ 100 ETF
QQMG
$204M
| $8K | ﹤0.01% |
437
-14
| -3% | -$281 |
|
8716
RAVE Restaurant Group
RAVE
$46.3M
| $8K | ﹤0.01% |
5,942
+5,892
| +11,784% | +$7.59K |
|
8717
Rocky Brands
RCKY
$378M
| $8K | ﹤0.01% |
400
-112
| -22% | -$3.21K |
|
8718
Arcadia Biosciences
RKDA
$1.42M
| $8K | ﹤0.01% |
+392
| New | +$13.4K |
|
8719
Ranger Energy Services
RNGR
$374M
| $8K | ﹤0.01% |
835
-2
| -0.2% | -$19 |
|
8720
374Water
SCWO
$38.7M
| $8K | ﹤0.01% |
292
+262
| +873% | +$7.66K |
|
8721
SunCar Technology Group
SDA
$80M
| $8K | ﹤0.01% |
806
-2,482
| -75% | -$25.3K |
|
8722
Scienjoy Holding
SJ
$42.5M
| $8K | ﹤0.01% |
3,528
+2,121
| +151% | +$8.43K |
|
8723
Sky Harbour Group
SKYH
$379M
| $8K | ﹤0.01% |
2,162
+744
| +52% | +$3.52K |
|
|
DCOY
8724
Decoy Therapeutics
DCOY
$2.32M
| $8K | ﹤0.01% |
1
| – | – |
|
8725
The ONE Group
STKS
$55.2M
| $8K | ﹤0.01% |
1,200
-145
| -11% | -$1.12K |
|
Similar funds
UBS Group's Q3 2022 Portfolio in Review
As of Q3 2022, UBS Group held 11,885 positions worth $228B, down 6.3% from $244B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group's Q3 2022 filing shows 1,174 new, 4,828 increased, 3,849 reduced and 1,024 closed positions. Its largest new stake was Fairlead Tactical Sector ETF: 824,803 shares worth $18.4M. The largest sale was iShares MSCI ACWI ETF, an estimated $630M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q3 2022 buy was Fairlead Tactical Sector ETF: 824,803 shares worth $18.4M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $324M increase.
- UBS Group's biggest Q3 2022 reduction was iShares MSCI ACWI ETF, cutting an estimated $630M.
- UBS Group fully exited CMC Materials, Inc. Common Stock in Q3 2022, selling an estimated $111M.
- UBS Group's ten largest holdings make up 14% of its $228B portfolio in Q3 2022.
- UBS Group opened 1,174 new positions and closed 1,024 in Q3 2022.
- UBS Group's portfolio value fell 6.3% quarter-over-quarter to $228B.
Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.